Drug intelligence / Profile preview

cannabis

Development stage
Phase 3
Lead developer
Jazz Pharmaceuticals
Administration
Inhalation, Oral
01

Overview

**Cannabis** is a non-single-entity botanical drug material obtained from Cannabis plants and containing a variable mixture of phytocannabinoids, terpenes, and other constituents. Its principal psychoactive constituent is typically delta-9-tetrahydrocannabinol, while cannabidiol and many other cannabinoids may also be present at highly variable concentrations. THC-mediated effects are principally produced through cannabinoid receptor 1 and cannabinoid receptor 2 signaling; therefore, the clinical pharmacology, efficacy, psychoactivity, and safety of cannabis depend substantially on chemotype, THC-to-CBD ratio, dose, route, and product preparation. Cannabis has been studied in defined inhaled, smoked, oral, and encapsulated preparations for pain, inflammatory bowel disease, cancer cachexia, respiratory symptoms, and inflammatory arthritis, but cannabis itself is not one standardized pharmaceutical chemical entity. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC5812699/))

Brand names
Thrive
Other names
marijuanamedical cannabismedical marijuana
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on cannabis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cannabis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call